Compare IZM & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IZM | TRIB |
|---|---|---|
| Founded | 2011 | 1992 |
| Country | China | Ireland |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6M | 18.3M |
| IPO Year | 2023 | N/A |
| Metric | IZM | TRIB |
|---|---|---|
| Price | $0.94 | $1.01 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 671.9K | 62.2K |
| Earning Date | 10-24-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $187,048,691.00 | $61,555,000.00 |
| Revenue This Year | N/A | $13.51 |
| Revenue Next Year | N/A | $13.14 |
| P/E Ratio | $9.40 | ★ N/A |
| Revenue Growth | 5.12 | ★ 8.31 |
| 52 Week Low | $0.90 | $0.48 |
| 52 Week High | $2.74 | $3.44 |
| Indicator | IZM | TRIB |
|---|---|---|
| Relative Strength Index (RSI) | 27.41 | 56.17 |
| Support Level | $0.92 | $0.80 |
| Resistance Level | $1.28 | $0.94 |
| Average True Range (ATR) | 0.11 | 0.08 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 8.00 | 80.20 |
ICZOOM Group Inc. operates an e-commerce platform selling electronic components to SMEs in China across consumer electronics, IoT, automotive, and industrial control sectors. It offers two main product categories: semiconductor products, including integrated circuits and optoelectronics, and electronic equipment and tools such as electromechanical and MRO supplies. The company also provides services like customs clearance, temporary warehousing, and logistics, earning additional commission fees. The majority of its revenue comes from electronic component sales.
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.